FdaApplication

BLA 761324

Back to search

Identifiers

Properties

PropertyValue
applicant_nameGenmab US, Inc.
application_typeBLA
approval_date2023-05-19

Products (2)

ProductActive ingredientStrengthDosage form
EPKINLYEPCORITAMAB-BYSP4MG/0.8MLInjection
EPKINLYEPCORITAMAB-BYSP48MG/0.8MLInjection

2 products